ursodeoxycholic acid has been researched along with Diabetic Glomerulosclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, AL; Chen, X; Chu, S; Guo, HJ; Liu, C; Peng, W; Wang, L; Wang, YM; Zhang, XM | 1 |
| Cao, A; Chen, X; Chu, S; Guo, H; Peng, W; Wang, L; Zhang, X | 1 |
| Arellano, A; Bautista, R; Coronel, I; Escalante, B; Franco, M; Osorio, H | 1 |
3 other study(ies) available for ursodeoxycholic acid and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy.
Topics: Albuminuria; Animals; Apoptosis; Autophagy; Cells, Cultured; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Phenylbutyrates; Podocytes; Receptors, Leptin; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Blood Glucose; Catalase; Cell Survival; Cells, Cultured; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Hyperglycemia; Kidney; Male; Malondialdehyde; Mice; Mice, Mutant Strains; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats.
Topics: Animals; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Immunohistochemistry; Kidney; Male; Oxidative Stress; Rats; Rats, Wistar; Sodium-Glucose Transporter 2; Ursodeoxycholic Acid | 2012 |